Final Flashcards
Morphine
strong opioid
fentanyl
strong opioid
hydromorphine
strong opioid
methadone
strong opioid
oxymorphone
strong opioid
oxycodone
strong opioid
codine
mild to moderate opioid
hydrocodone
mild to moderate opioid
-phine
mixed agonist antagonist opioid
Naloxone and naltrexone
opioid antagonists
mechanism of opioids
bind to mu, delta and kappa to close the presynapic Ca channels and open K channels on the post synaptic
tolerance of opiods have no effect on
miosis, constipation, and convulsions
opioid toxicity triad
1) CNS depression
2) respiratory depression (cyanosis)
3) miosis
s/s of opioid overdose
- euphoria
- unconsciousness
- respiratory depression
- pulmonary edema
- seizures
- hypothermia
- death
what are non-opioid analgesics
NSAIDS and acetaminophen
Asprin
NSAID
Ibuprofen
NSAID
indomethacin
NSAID
meloxicam
NSAID
celecoxib
non selective NSAID
side effects of NSAIDS
- kidney failure
- liver failure
- ulcers
- edema
- n/v
- dirrehea or constipation
- decreased appitite
indications for acetaminophen
fever and OA
contraindications for acetaminophen
- reyes syndrome
- liver disease/toxicity
inflammatory drugs
steroids and NSAIDS
-sone
steroids
MOA of steroids
binds to GRE to suppress cytokines
side effects of steroids
- adrenal shock: causes leg pain
- breakdown of tissues: decrease collagen
- crushing syndrome: hypercortisol
- decrease ability to absorb Ca2+: osteoporosis
Baclofen
Gaba B agonist - used for antispastisity
side effects of baclofen
sedation and weakness
diazepam (valium)
gaba A agonist for antispastisity and anti spasm
side effect of diazepam
coma or death
antidote for diazepam
flumazenil
tizanidine
alpha 2 adrenergic for antispasticity
SE of tizanidine
weakness, hypotension, sedation
dantrolene
blocks Ca for antispasticity
SE of dantrolene
weakness
botulinum toxin
decreases AcH in NMJ for anti spasticity
gabapentin
increases gaba used for anti spasticity or chronic pain
SE of gabapentin
sedation, fatigue, dizziness, ataxia
carisoprodol
anti spasm / polysynaptic inhibitor
cyclobenzaprine
anti spasm / polysynaptic inhibitor
methocarbamol
anti spasm / polysynaptic inhibitor
orphenadrine
anti spasm / polysynaptic inhibitor
SE of spasmotics
1) drowsiness/dizziness
2) Nausea, lightheadedness, vertigo, ataxia
classes of drugs that can be used in RA treatment
1) NSAIDS
2) Steroids
3) DMARDS
hydrozychlorquine
traditional DMARD
methotrexate
traditional DMARD
leflunomide
traditional DMARD
sulfasalzine
traditional DMARD
-mab -cept
biologic DMARD
SE of DMARDS
local injection site reaction, infection, maligancy
Drugs used for OA
1) acetaminophen
2) NSAIDS
3) Hyaluronic acid
4) chondroitin sufate
SE of hyaluronic acid
- pain at injection site
- joint stiffness
- headache
note: can cause temporary pain and swelling avoid strenuous activites for a couple of days
SE of chondroitiin sulfate
- stomach pain
- n/v
- diarrhea
- headache
- swelling
Drugs classes for osteoporosis
1) biophosphonates
2) SERMS
3) Calcitonin
4) RANKL inhibitor
5) PTH
6) ca and vit D
-onate
biophosphonates
MOA of biophosphonates
inhibit osteoclasts
SE of biophasphonates
acid reflex (do not take on an empty stomach)
Raloxifene
SERMS
MOA of raloxifene
mimic estrogen to decrease bone resorption
MOA of calcitonin
decrease osteoclast
SE of calcitonin
nasal irritation
Denosumab
RANKL inhibitor
MOA of densumab
decrease osteoclasts by inhibiting RANKL
SE of densumab
osteonecrosis of the jaq
-paratide
PTH
MOA of PTH
increase the work of osteoblasts
what are the common SE of drugs for osteoporosis
leg cramp and hot flash
what drugs should be administered on days that pt is NOT attending PT
calcitonin, SERMS, and teriparatide
sympathetic tone
controls BP even at rest through vasoconstriction, thermoregulary, renin release, and sweat gland only have sympathetic (other then that increase HR, brochodilation
parasympathetic tone
slows hear and increases GI
“rine” and “zoline”
alpha 1 agonists
therapeutic effect of alpha 1 agonists
decrease nasal congestion
SE of alpha 1 agonists
increase BP
reflex brady
headache
clonidine
alpha 2 selective agonist
methydopa
alpha 2 selective agonist
therapeutic effects of alpha 2 selective agonist
anti HTN
SE of alpha 2 selective agonist
1) dizziness
2) drowsiness
3) dry mouth
-osin and phenoxybezamine
alpha 1 selective antagonist
therapeutic effect of alpha 1 selective antagonist
anti-HTN and urinary retention in benign prostatic hyperplasia
SE of alpha 1 selective antagonist
- orthostatic hypotension
- reflex tachy
- dizziness
-amide
beta 1 selective agonist
theraputic effect of beta 1 selective agonist
positive iontrop/ increases the HR
SE of beta 1 selective agonist
1) arrhythmia
2) SOB
3) chest pain
“erols” and terbutaline
beta 2 selective agonists
theraputic used for beta 2 selective agonist (erols)
bronchodialtion
theraputic use for beta 2 selective agonist (terbutaline)
delay preterm labor
SE of beta 2 selective agonist
- nervousness
- restlessness
- trembling
olol
beta antagonist (beta blocker)
theraputic uses for beta blockers
anti HTN
angina
HF
SE of beta blockers
- bronchoconstriction
- bradycardia
- dizziness
- depression
- lethargy
amphetamines
non selective alpha and beta agonist for ADD and narcolepsy
epinephrine
non selective alpha and beta agonist for anaphylatic shock
norepinephrine
non selective alpha and beta agonist for hypotensive shock
SE of non selective alpha and beta agonist
- anxiety
- HTN
- Arrhythmia
Hyoscyamine
anti cholinergic
dicyclomide
anti cholinergic
bromide bros
anti cholinergic - bronchodilators
benztropine
anti cholinergic
oxybutynin
anti cholinergic
tolterodine
anti cholinergic
atropine
anti cholinergic - eyes and heart
tropicamide
anti cholinergic - eyes
scopolamine
anti cholinergic - motion sickness
bethanechol
direct acting cholinergic agonist (ACH)
pilocarpine
direct acting cholinergic agonist (ACH)
methacholine
direct acting cholinergic agonist (ACH)
carbachol
direct acting cholinergic agonist (ACH)
donepezil
indirect acting cholinergic agonist for AD
rivastigmine
indirect acting cholinergic agonist for AD
galantamine
indirect acting cholinergic agonist for AD
neostigmine
indirect acting cholinergic agonist for myastenia gravis
pyridostigmine
indirect acting cholinergic agonist for myastenia gravis
edrophonium
indirect acting cholinergic agonist for myastenia gravis
ambenonium
indirect acting cholinergic agonist for myastenia gravis
physostigmine
indirect acting cholinergic agonist for glaucoma
echothiopate
indirect acting cholinergic agonist for glaucoma
SE for cholinergic agents (agonists)
- GI
- increase salvation
- increase lachrymation
- bronchoconstriction
- bradycardia
- visual accommodation
anti HTN drug classes
1) alpha 2 agonists
2) beta blockers
3) ace inhibitors
4) ARB
5) CCB
6) diuretics
7) alpha blockers
8) vasodilators
MOA of alpha 2 agonists
decrease NE release leading to vasodilation
-prils
ACE inhibitors
MOA of ACE inhibitors
block the conversion of agiotension 1 to angiotension 2 thus decreasing the absorption of na and H20. decrease in blood volume, BP and vasodilation
SE of ACE inhibitors
- dry cough
- hyperkalemia
- kidney damage
- edema
- fetotoxic
“sartan”
ARBS
MOA of ARBs
blocks angiotension receptors to decrease blood volume, BP and vasodilation
SE of ARBs
- actue kidney disease
- hyperkalemia
- fetotoxic
aliskiren
renin inhibitor do not take while pregnant
“dipines” vera and diltia
CCB
MOA of CCB
decreases calcium thus decreasing vasocontriction
CCB side effects
- dizziness
- flusing
- headache
- fatigue
- peripheral edema
Types of dieretics
thiazie “thiazide”
loop “semide”
K sparing (spirolactone and triameterene)
SE of diuretics
- orthostatic hypotension
- confusion
- irritability
- weakness
- cardiac arrthmias
- electrolyte imbalance
hydralazine
vasodilator for anti HTN
minoxidil
vasodilator for anti HTN
SE of vasodilators for anti HTN
- othostatic hypo
- reflex tachy
- incrase in renin
quinidine
class 1 A antiarrhythmic increases refractory period
procainamide
class 1 A antiarrhythmic increases refractory period
disopyramide
class 1 A antiarrhythmic extended duration of action potenial treat ventricular arrythmias
lidocaine
class 1B antiarrhythmic - blocks NA channels ventricular arrhythmias
mexiletine
class 1B antiarrhythmic - blocks NA channels ventricular arrhythmias
flexainide
class 1 C antiarrhythmia slows conduction- ventricular arrhythmias
propafenone
class 1 C antiarrhythmia slows conduction- ventricular arrythmias
class 2 anti arrythmics
beta blockers work on phase 4 slowing SA node for atrial tachy and ventricular arrhytmias
class 3 antiarrhythmics
“darone” “tilide” K channel blockers. Delay in repolarization (phase 3)
class 4 antiarrhythmic
CCB (vera and diltia) slows SA node in phase 2 good for a fib
Other tachyarrhythmic drugs
1) adenosine (inhibits AV conduction)
2) digoxin (reduces AV conduction)
3) Atropine (block vagal effect on SA to treat bradycardia)
what are the SE of class 3 K channel blockers
- pulmonary toxicity
- thyroid dysfunction
- hepatotoxicity
- corneal deposits
classes of drugs used for anti-anginal
1) organic nitrate
2) b-blockers
3) CCB
4) sodium channel blockers
MOA of organic nitrate
increases nitric oxide which increases cGMP activating the MKLC causing vasodilation
SE of organic nitrates
- headache
-orthostatic hypo - facial flushing
- tachycardia
ranolazine
sodium channel blocker used in antiangina
MOA of ranolazine
decrease Na to decrease ca overload leading to increased diastolic function
SE of ranolazine
- dizziness
- headache
- constipation
- QT prolongation
classes of drugs used for HF
1) diuretics
2) Ace inhibitor
3) ARB
4) beta blockers
5) aldosterone receptor antagonist
6) cardiac glycosides (positive iontrops)
7) vasodilators
“tanide” “semide” and metalazone
diuretics used in HF
spironolactone
aldosterone recepter antagonist: prevents salt retention, myocardial hypertrophy and hypokalemia
eplerenone
aldosterone receptor antagonist that decreases endocrine effects
MOA of digoxin
increase sodium and potassium pump enhancing vagal tone by being a positive iontrop but not increasing HR
SE of digoxin
- narrow T.I.
- anorexia
- N/V
- blurred vision
- cardiac arrhythmias
- hypokalemia
MOA of milrone
increasing cAMP creating an increase in HR and positive iontrop (for HF) beta adrenergic effect
MOA of dobutamine
increaseing cAMP creating an increase in HR and positive iontrop for HF beta anrenergic effect and phosphodiasterase inhibitor
vasodilators used in HR
nitrates and hydralazine
SE of nirtrates and hydralazine
- headache
- hypotension
- tachycardia
what HF drugs reduce mortality
ACE inhibitors
beta blockers
aldosterone receptor antagonists
MOA of anticoagulants
inhibit production of thrombin
anti coagulant drugs
1) vit k antagonist
2) herprin
3) direct thrombin inhibitor
4) factor XA inhibitors
vit k antagonist
warfin
SE of warfin
1) hemorrhage
2) teratogenesis
-eprins
heparin
heparin side effect
- bleeding
- thrombocytopenia
- osteoporosis
- hyper sensitivity
-tran, -troban, -rudin
direct thrombin inhibitors
SE of direct thrombin inhibitors
- bleeding
-GI
xa in the middle and fonda
factor xa inhibitors
SE of xa inhibitors
- bleeding
- pain in limbs
- headache
- dizziness
- abdominal pain
Antithrombolitics classes of drugs
1) Cox inhibitor- Asprin
2) ADP/P2Y12 inhibitors (grels)
3) PDE (-mole)
4) glycoprotein 2A and B (abc mab and trofiban)
MOA of antithrombolitics
prevent platelet plug
SE of anti thrombolitics
- bleeding
- GI
- Tinnitus (asprin)
- thromboltic thrombocytopenic purpura (clopidgrel)
-place and -kinase
thrombolitics
SE of thrombolytics
- bleeding
- allergic reaction
- re-occusion
MOA of thrombolytics
activate plasminogen to plasmin
hemostatics
opposite MOA as throbolytics decrease conversion of plasminogen to keep clots (acids)
classes of drugs for hyperlipidema
1) statins
2) bile acide sequestrants
3) ezetimeibe
4) fibrates
5) omega 3 fatty acid
6) niacin
7) PCSK inhibitors
MOA of statins
inhibit production of cholesterol in the liver by inhibiting HMG-CoA
side effects of statins
- muscle pain and weakness
- fatigue
- rhadomyolysis (muscle breakdown leading to kidney damage)
cole and chole
bile acide sequestrants
MOA of bile acid sequestrants
decrease bile in small instestine thus increasing production of bile from cholesterol in the liver
SE of bile acid sequestrants
- constipation
- bloating
- indigestion
-nausea
MOA of ezetimibe
inhibit absorption if cholesterol in the small intestine
SE of ezetimibe
- dirrhea
- sinusitis
- fatigue
- joint pain
MOA of fenfibrate and gemfibozil
enhancing PPAR alpha receptors thus increasing LDL absorption in the liver
SE of fenfibrate and gemfibozil
- GI
- increase in liver enzymes
- gallstones
- myopathy
- increase creatine levels
- skin rashes
lovaza
omega 3 fatty acid
vascepa
omega 3 fatty acid
I E
omega 3 fatty acid
MOA of niacin
increase HDL and decrease VLDL
Evolocumab
PCSK9 inhibitor
alirocumab
PCSK9 inhibitor
MOA of PCSK9 inhibitor
removal of LDL from blood stream
SE of PCSK9 inhibitor
- nasopharyngitis
- injection site reaction
- flu symptoms
- back pain
Oral DM drugs
1) sulfonylureas
2) meglitinides
3) metformin
4) thiazolidediones
5) alpha-glucosidase inhibitors
6) DPP- 4 inhibitor
7) GLP 1 analogs
8) sodium glucose transporter inhibitor
(gl-ide)
sulfonylureas
MOA of sulfonylureas
block SURI increasing insulin release from the pancreas
SE of sulfonylureas
- hypoglycemia
- cholestatic jaudice
- wt gain
- fetal hypoglycemia
glinide
meglitinides
moa of meglitinides
stimulated short lived insulin release
SE of meglitinides
- hypoglycemia
- wt gain
MOA of metformin
decrease liver glucose production and increase liver sensitivity
SE of metformin
- wt loss
- decrease LDL increase HDL
- GI
-Lactic acid
glitazone
thiazolidediones
MOA of thiazolidediones
enhance glucose metabolism through PPAR Y opening GLUT 4
SE of thiazolidediones
- wt gain
- fuild retention/edema
- risk of fx
acarbose
alpha glucosidase inhibitor
miglitol
alpha glucosidase inhibitor
MOA of alpha glucosidase inhibitor
delays absorption of glucose from the small intestine
SE of alpha glucosidase inhibitor
- futulence
- diarrhea
- abdominal pain
gliptin
DPP 4 inhibitor
MOA of DPP 4 inhibitor
provent the breakdown of GLP1 thus increasing insulin secreation from the pancreas and decreasing glucose output from muscle, adipose and liver
SE of DPP 4 inhibitor
- nasopharyngitis (UR tract)
- headache
- pancreatitis
E, L, S -tide
GLP-1 analogs
MOA of GLP-1 analogs
increase glucose dependent insulin secretion and decrease glucose output
SE of GLP-1 analogs
- GI issues
- injection site reaction
- pancreatitis
gliflozin
Sodium-glucose transporter inhibitor (SGLT-2)
MOA of Sodium-glucose transporter inhibitor (SGLT-2)
decrease glucose reabsorption in kidney
SE of Sodium-glucose transporter inhibitor (SGLT-2)
- genital yeast infection
- UTI
- bone FX
- ketoacidosis
drugs for ashma
1) beta 2 agonists
2) anticholinergic (bromide bros)
3) steriods
4) theophylline
5) mast inhibitors
6) leukotrine medifiers
leukotrine receptor agonists
- lukast
5-lipozygenase inhibitor
(leu)
MOA of leukotrine modifiers
block leukotriene receptors or inhibit enzyme 5 lipozygenase thus decreasing inflammation
SABA
albuterol and levalbuterols
LABA
salmeterol and formoterol
MOA of mass cells
decrease inflammation
omalizumab
monoclonal antibody for ashma
classes of drugs for COPD
1) anticholinergic and beta agonists
2) steroids
3) phosphodiesterase 5 inhibitors
roflumilast
phosphodiesterase 5 inhibitor
SE of roflumilast
- wt loss
- diarrhea
- nausea
- headache
- insomnia
Classes of drugs for PD
1) dopamine agonist
2) dopamine precursor
3) MAO inhibitors
4) COMT inhibitors
pramipexole
dopamine agonist D3
Ropinirole
dopamine agonist D2
rotigotone
dopamine agonist D2
SE of dopamine agonist
- sedation
- hallucinations
- nausea
- orthostatic hypo
- dyskinesias
MOA of carbidopa
block DDC in the GI
SE of sinement
- GI issues
- nausea
- anorexia
- hypotension
- psychotropic
- dyskinesias
MOA inhibitor for PD
-giline and safinamide
MOA of monoamine oxidase inhibitor (PD)
prevent dopamine breakdown in the brain
SE of monoamine oxidase inhibitor (PD)
- seratonin syndrome
- increases the effects of levodopa
-capone
COMT inhibitor
MOA of COMT inhibitor
inhibit catechol-o-methyl transferase in the periphery and the brain
SE of COMT inhibitor
- increase levodopa toxicity
- dyskinesias
- confusion
- acute liver failure
drugs for MS exasterbation
ACTH and steriords
injectable MS modifying disease progression drugs
internon beta 1a and 1b
glatiramer acetate
fingolimod
MS modifying disease progression drugs oral
diamethyl fumarate
MS modifying disease progression drugs oral
mitozantrone
MS modifying disease progression drugs infused
ocrelizumab
MS modifying disease progression drugs infused primary progressive
natalizumab
MS modifying disease progression drugs infused
common side effects of MS drugs
- muscle weakness
- fatigue
- dizziness
- heat sensitivity
- decline in cognitive function
- dizziness
MS fatigue
Amantadine and methylphenidate
MS spasticity
baclofen, dantrolene, tizanidine
MS bladder
oxybutynin and prazosin
MS sensory
gaba pentin and pregabalin
MS ambulation
dalfampride
MOA of dalfampride
k channel blocker
SE of dalf
UTI, back pain, and sesurzes
classes of drugs for sedative hypnotic and anti-anxiety
1) benzodiapine
2) non benzodiapines (Z, meletonin, orexin)
3) atypical anti anxiety
lam and pam
suffixes for benzodiapine
MOA of benzodiapine
enhance gaba a thus allowing more Cl- to enter the cell to hyperpilarize thus decreasing cell excitability
affects of benzodiapine
- decrease anxiety
- induce sleep
- anticonvulsant effect
- reduction of muscle tone and coordination
- effects on respiration
- CVS effects
SE of benzodiapine
- hangover
- motor impairment
- rebound insomnia
- confusion
- potentates CNS effect with ethanol
antidoate for benzodiapine
flumazenil
zol,zal, and Esz
Z drugs
MOA of Z drugs
bind to gaba in the brain
SE of Z drugs
- GI
- headache
- dizziness
-melteon
suffix for melatonin receptor agonist
SE of melatonin receptor agonist
headache, dizziness, nightmares, somnolence, hepatotoxicity (tasi)
-orexant
orexin receptor antagonists
MOA of orexin receptor antagonists
block orexin receptors 1 and 2
SE of orexin receptor antagonists
somnolence
atypical antianxiety drugs
- buspirone
- SSRI
- SNRI
- TCAs
MOA of buspirone
agonist for serotonin 5-HT1A receptors
drugs for mild to mod AD
Don, Riv and the Gals
MOA of don riv and the gals
increase ACH by blocking ecetylcholinesterase
drug for severe AD
mematine
MOA of mematine
NMDA receptor antagonist preventing Ca excitotoxicity
SE of mematine
- headache
- consipation
- dizziness
- confusion/hallucinations
aducanumab
amyloid beta directed antibody for AD
Anti depression drug classes
1) SSRI
2) SNRI
3) NDRI
4) TCA
5) Moa inhibitors
SSRI drugs
-lopram, fluoxetine, sertraline
MOA of SSRI drugs
inhibit 5-HT
SE of SSRI
sexual
somnolence
insomnia
headache
hyponatremia
SNRI drugs
-lafax and -oxetine
MOA of SNRI drugs
inhibit seretonin and NE transporters
SE of SNRI
- sexual
- somnolene
- insomnia
- headache
- hypoatremia
- increased HR
- dry mouth
Bupropion
NDRI
MOA of bupropion
inhibit the reuptake of NE and dopamine
SE of bupropion
- insomnia
- tremors
- seizures
- wt loss
Tricyclic antidepressent suffix
-triptyline
MOA of TCAs
inhibit NR and serotonin uptake
SE of TCA
- QT prolongation
- orthostatic hypo
- anticholinergic effect
- vivid dreams
- wt gain
moclobemide
MAO inhibitor for anti depression
phenelzine
MAO inhibitor for anti depression
MOA of MAO inhibitor for anti depression
inhibiton of MAO and RIMA
SE of MAO inhibitor for anti depression
- sedation
- orthostatic hypotension
- sexual
- hypertensive crisis
food to avoid with MAO inhibitor for anti depression
tyramine
braxanolone
drug for post partum depression
MOA of brazanolone
modulate GABA a receptors to increase 5HT and NE transmittion
SE of brazanolone
- headache
- somnolence
- dizziness
manic bipolar drugs
lithium and divalproex
Long term SE of manic bipolar drugs
- hypothyroidism
- cardiac effects
- wt gain
- leukocytosis
- dermatological effects
depressive bipolar drugs
lithium Aripipi, que ris (the) lam
Dronabinol
FDA approved cannabinoid to stimulate appetite and minigate N/V in aids and cancer pts
nabilon
FDA approved cannabinoid for N/V chemo specific
cannabidol
FDA approved cannabinoid for epilepsy